Description
Laprituximab (J2898A) is a humanized IgG1 anti- EGFR antibody that can be used for the synthesis of ADC IMGN289.In VivoIn the H292 xenograft tumor model, the minimally effective doses of Laprituximab (J2898A) is 3 mg/kg. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Liquid